Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Akira Dobashi, Kaori Kurata, Mitsuhiro Okazaki & Mari Nishizawa. (2016) Analysis of spontaneous inquiries about suspected adverse drug reactions posted by the general public on the electronic Japanese bulletin board “Yahoo! Japan Chiebukuro”. Patient Preference and Adherence 10, pages 511-521.
Read now
Read now
Michiko Yamamoto, Kiyoshi Kubota, Mitsuhiro Okazaki, Akira Dobashi, Masayuki Hashiguchi, Hirohisa Doi, Machi Suka & Mayumi Mochizuki. (2015) Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan. Patient Preference and Adherence 9, pages 173-184.
Read now
Read now
Articles from other publishers (22)
J. Riera-Arnau, L. A. Alvarado Aguirre, N. Garcia Doladé, X. Vidal Guitart, A. Figueras & G. Cereza García. (2020) Patients’ contribution to drug safety in Catalonia: the interest of personal feelings on adverse drug reactions. European Journal of Clinical Pharmacology 77:4, pages 637-642.
Crossref
Crossref
Halimat Adedeji-Adenola & Manimbulu Nlooto. (2020) Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review. International Journal of Clinical Pharmacy 43:1, pages 11-24.
Crossref
Crossref
Rania Al Dweik, Sanni Yaya, Dawn Stacey & Dafna Kohen. (2020) Patients’ experiences on adverse drug reactions reporting: a qualitative study. European Journal of Clinical Pharmacology 76:12, pages 1723-1730.
Crossref
Crossref
Rania Al Dweik, Dafna Kohen, Dawn Stacey & Sanni Yaya. (2020) Adverse drug reaction reporting in Canada: consumer versus physician reports. Drugs & Therapy Perspectives 36:10, pages 469-475.
Crossref
Crossref
Paula Lana de Miranda Drummond, Roberta Márcia Marques dos Santos, Cristine de Araújo Silva & Cristiane Aparecida Menezes de Pádua. (2020) Pharmacovigilance of thalidomide in the Brazilian Health System and patient safety. Brazilian Journal of Pharmaceutical Sciences 56.
Crossref
Crossref
Gerald J. Dal Pan, Marie Lindquist & Kate Gelperin. 2019. Pharmacoepidemiology. Pharmacoepidemiology
165
201
.
Leàn Rolfes, Florence van Hunsel, Ola Caster, Henric Taavola, Katja Taxis & Eugène van Puijenbroek. (2018) Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database. British Journal of Clinical Pharmacology 84:7, pages 1514-1524.
Crossref
Crossref
Yasuko Inokuma, Yasunori Sato & Sachiko Masuda. (2018) Adverse Event Reporting Patterns of Marketing Authorization Holders, Healthcare Professionals and Patients in Japan: Lessons Learnt From the Human Papilloma Virus Vaccine. Pharmaceutical Medicine 32:2, pages 123-129.
Crossref
Crossref
George Tsey Sabblah, Delese Mimi Darko, Hudu Mogtari, Linda Härmark & Eugène van Puijenbroek. (2017) Patients’ Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana. Drug Safety 40:10, pages 911-921.
Crossref
Crossref
Rania Al Dweik, Sanni Yaya, Dawn Stacey & Dafna Kohen. (2016) Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study—study protocol. SpringerPlus 5:1.
Crossref
Crossref
Jonathan Luke Richardson, Sally Stephens, Simon Hugh Lynton Thomas, Anna Jamry-Dziurla, Lolkje de Jong-van den Berg, Priscilla Zetstra - van der Woude, Maja Laursen, Valerie Hliva, Shahrul Mt-Isa, Alison Bourke, Nancy A Dreyer & Stella CF Blackburn. (2016) An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. JMIR Public Health and Surveillance 2:1, pages e13.
Crossref
Crossref
Gianmario Candore, Kristina Juhlin, Katrin Manlik, Bharat Thakrar, Naashika Quarcoo, Suzie Seabroke, Antoni Wisniewski & Jim Slattery. (2015) Comparison of Statistical Signal Detection Methods Within and Across Spontaneous Reporting Databases. Drug Safety 38:6, pages 577-587.
Crossref
Crossref
Kiyoshi Kubota, Mitsuhiro Okazaki, Akira Dobashi, Michiko Yamamoto, Masayuki Hashiguchi, Arisa Horie, Ataru Inagaki, Toshiaki Kikuchi & Mayumi Mochizuki. (2013) Temporal relationship between multiple drugs and multiple events in patient reports on adverse drug reactions: findings in a pilot study in Japan. Pharmacoepidemiology and Drug Safety 22:10, pages 1134-1137.
Crossref
Crossref
James H. Lewis. (2013) Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist. Pharmaceutical Medicine 27:3, pages 165-191.
Crossref
Crossref
A. Neubert & W. Rascher. (2013) Neue EU-PharmakovigilanzverordnungThe new EU Pharmacovigilance legislation. Monatsschrift Kinderheilkunde 161:4, pages 308-315.
Crossref
Crossref
Dongyi “Tony” DuJohn GoldsmithKathryn J. AikinWilliam E. EncinosaClark Nardinelli. (2012) Despite 2007 Law Requiring FDA Hotline To Be Included In Print Drug Ads, Reporting Of Adverse Events By Consumers Still Low. Health Affairs 31:5, pages 1022-1029.
Crossref
Crossref
Florence van Hunsel, Linda Härmark, Shanthi Pal, Sten Olsson & Kees van Grootheest. (2012) Experiences with Adverse Drug Reaction Reporting by Patients. Drug Safety 35:1, pages 45-60.
Crossref
Crossref
J.-M. Januel, C.-M. Couris, J.-C. Luthi, P. Halfon, B. Trombert-Paviot, H. Quan, S. Drosler, V. Sundararajan, E. Pradat, S. Touzet, E. Wen, J. Shepheard, G. Webster, P.S. Romano, L. So, L. Moskal, L. Tournay-Lewis, L. Sundaresan, E. Kelley, N. Klazinga, W.A. Ghali, C. Colin & B. Burnand. (2011) Adaptation au codage CIM-10?de 15?indicateurs de la s?curit? des patients propos?s par l?Agence ?tasunienne pour la recherche et la qualit? des soins de sant? (AHRQ). Revue d'?pid?miologie et de Sant? Publique 59:5, pages 341-350.
Crossref
Crossref
Florence van Hunsel, Attje Talsma, Eug?ne van Puijenbroek, Lolkje de Jong-van den Berg & Kees van Grootheest. (2011) The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study. Pharmacoepidemiology and Drug Safety 20:3, pages 286-291.
Crossref
Crossref
Rishma Walji, Heather Boon, Joanne Barnes, Zubin Austin, Sandy Welsh & G Ross Baker. (2010) Consumers of natural health products: natural-born pharmacovigilantes?. BMC Complementary and Alternative Medicine 10:1.
Crossref
Crossref
Matthew Clark & Jeffrey S. Wiseman. (2009) Fragment-Based Prediction of the Clinical Occurrence of Long QT Syndrome and Torsade de Pointes. Journal of Chemical Information and Modeling 49:11, pages 2617-2626.
Crossref
Crossref
AM Hochberg & M Hauben. (2009) Time-to-Signal Comparison for Drug Safety Data-Mining Algorithms vs. Traditional Signaling Criteria. Clinical Pharmacology & Therapeutics 85:6, pages 600-606.
Crossref
Crossref